BCRX
BIOCRYST PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$8.68
−0.23%Forward multiples
Based on analyst estimates
- P/E forward
- 16.73x
- P/E 2026E
- —
- P/E 2027E
- 14.91x
- P/E 2028E
- 12.19x
- P/S forward
- 3.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -4.88x
- Price / sales
- 2.36x
- Price / cash flow
- 6.16x
Enterprise value
- Enterprise value
- $2.3B
- EV / sales
- 2.42x
- EV / EBITDA
- -7.51x
- EV / EBIT
- -7.27x
- Market cap
- $2.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026